MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Delcath Systems EPS Ratio 2011-2026 | DCTH
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Delcath Systems
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.93 | -2.94 | -4.12 | -3.59 | -8.35 | -343 | -0.72 | -3.25 K | -3.71 K | -0.91 | -1.84 | -0.3 | -0.85 | -0.68 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.3 | -3.71 K | -523 |
Quarterly EPS Ratio Delcath Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 0.08 | 0.03 | - | 0.06 | -0.48 | -0.45 | - | -1.14 | -0.58 | -0.77 | - | -0.96 | -1.24 | -1.1 | - | -0.94 | -0.96 | -1.04 | - | -1.16 | -1.9 | -108 | - | -73.8 | -58.5 | -75.1 | - | -0.25 | -7.26 | 10.9 | -0.75 | -4.56 K | -1.37 K | -45.7 K | -1.29 K | -231 | -4.41 | -438 | -0.23 | -1.96 | -0.3 | -0.32 | -0.31 | -0.48 | -0.49 | -0.57 | -0.04 | -0.07 | -0.91 | -0.15 | -0.14 | -0.18 | -0.26 | -0.31 | -0.32 | -0.18 | -0.13 | -0.04 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 10.9 | -45.7 K | -1.04 K |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
-0.23 | $ 33.35 | 2.25 % | $ 1.48 B |  USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
-2.81 | - | -26.83 % | $ 2.62 M | USA |
 |
Aziyo Biologics
AZYO
|
-2.07 | - | 1.37 % | $ 20.5 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-0.17 | $ 7.09 | 3.2 % | $ 509 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
-0.54 | $ 3.85 | 0.79 % | $ 133 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.13 | $ 13.41 | 2.33 % | $ 1.92 B | USA |
 |
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | USA |
 |
Bio-Rad Laboratories
BIO
|
-25.6 | $ 259.84 | -10.91 % | $ 7.33 B | USA |
 |
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
0.76 | $ 36.2 | -3.51 % | $ 5.39 K | USA |
 |
BioSig Technologies
BSGM
|
-0.75 | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
4.29 | $ 42.01 | 0.74 % | $ 1.3 B | USA |
 |
Boston Scientific Corporation
BSX
|
1.26 | $ 75.35 | 1.66 % | $ 111 B | USA |
 |
Abbott Laboratories
ABT
|
7.67 | $ 112.29 | 0.73 % | $ 195 B | USA |
 |
Cardiovascular Systems
CSII
|
-0.94 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-2.87 | - | -10.19 % | $ 1.99 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-0.51 | $ 4.79 | 0.42 % | $ 179 M |  France |
 |
ClearPoint Neuro
CLPT
|
-0.7 | $ 13.81 | 5.9 % | $ 373 M | USA |
 |
Electromed
ELMD
|
0.89 | $ 23.82 | 2.21 % | $ 201 M | USA |
 |
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-39.7 | - | - | $ 10.2 M | USA |
 |
Inogen
INGN
|
-1.52 | $ 5.88 | 1.52 % | $ 139 M | USA |
 |
InMode Ltd.
INMD
|
2.29 | $ 14.32 | 0.14 % | $ 1.14 B | Israel |
 |
GBS
GBS
|
-2 | - | -0.57 % | $ 7.12 M | USA |
 |
IRadimed Corporation
IRMD
|
1.52 | $ 101.26 | 1.42 % | $ 1.28 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.57 | $ 85.84 | 0.68 % | $ 2.88 B | USA |
 |
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | USA |
 |
Penumbra
PEN
|
0.36 | $ 340.3 | 0.46 % | $ 13.1 B | USA |
 |
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
1.78 | $ 18.54 | - | $ 122 M | USA |
 |
Globus Medical
GMED
|
0.76 | $ 89.17 | 2.24 % | $ 12.1 B | USA |
 |
Pulmonx Corporation
LUNG
|
-1.44 | $ 1.49 | 4.93 % | $ 58.3 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-0.09 | $ 11.52 | 6.57 % | $ 887 M | USA |
 |
Myomo
MYO
|
-1.52 | $ 0.81 | 1.15 % | $ 5.71 M | USA |
 |
Establishment Labs Holdings
ESTA
|
-3 | $ 72.85 | -0.94 % | $ 2.05 B |  Costa-rica |